Work

Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question

Year: 1991

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Pain

DOI: 10.1016/0304-3959(91)90052-y

Authors: Michel D. Ferrari, Marcia Wilkinson, Dorothea Hirt, Xavier Lataste, Marianne Notter

Institutions: National Migraine Centre, Sandoz Group AG (Switzerland)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2042434951

FWCI: 2.5

Cites: 26

Cited by: 27

Related to: 10